Scientists have identified a previously underappreciated brain signaling pathway that helps the body recognize when it is time to stop eating, shifting attention from neurons alone to a broader cellular network. The work, published April 6, 2026 in Proceedings of the National Academy of Sciences, focuses on how the hypothalamus processes post-meal fuel signals.
The study centers on astrocytes, abundant brain cells long viewed mainly as support for neurons, and suggests they can actively shape appetite control. Researchers say this mechanism could eventually inform new strategies for obesity and eating-disorder treatments, though the findings are based on animal experiments.
How glucose signals reach the brain
After a meal, glucose levels rise and are sensed in part by tanycytes, specialized cells that line fluid-filled spaces in the brain. In the experiments, tanycytes responded to glucose by producing lactate, a metabolic byproduct that can function as a signaling molecule in the surrounding tissue.
For years, lactate was often discussed as a signal that could act directly on appetite-regulating neurons. This research argues the message commonly takes an additional step, with astrocytes serving as a crucial intermediary before neurons that promote satiety are engaged.
Astrocytes as appetite messengers
The team found that astrocytes detect lactate via a receptor known as HCAR1 and, once activated, can release glutamate to influence nearby neurons. In this model, that astrocyte-to-neuron signal increases the excitability of POMC neurons, a population associated with suppressing appetite.
In closely observed lab tests, stimulating glucose handling in a single tanycyte led to broader astrocyte activity nearby, suggesting the signal can spread through a local network. The researchers also described evidence consistent with a dual effect in the hypothalamus, potentially supporting satiety pathways while dampening hunger-promoting activity through separate routes.
What this means for obesity research
Because tanycytes and astrocytes exist across mammals, the authors argue the same kind of circuitry could plausibly operate in humans, but that remains to be confirmed. The next step, they say, is testing whether changing HCAR1 activity in astrocytes can reliably alter eating behavior.
No approved drugs currently target this exact astrocyte pathway, and translating such findings into therapies typically requires years of follow-up work. Still, the researchers suggest that aiming at astrocyte signaling could one day complement existing anti-obesity approaches rather than replace them.
The project reflects a long-running collaboration between the University of Concepción in Chile and the University of Maryland. The authors report the work was supported by Chilean research funding programs and the U.S. National Institutes of Health.
Leave a Reply